{
    "Trade/Device Name(s)": [
        "FilmArray BCID2 Control Panel M416"
    ],
    "Submitter Information": "Maine Molecular Quality Controls, Inc.",
    "510(k) Number": "K200010",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190222"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "April 2, 2020",
    "Summary Letter Received Date": "January 2, 2020",
    "Submission Date": "December 30, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed Quality Control Material for Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "mycology",
        "misc"
    ],
    "Analyte(s)": [
        "CTX-M",
        "IMP",
        "KPC",
        "mcr-1",
        "mecA/C",
        "MREJ (MRSA)",
        "NDM",
        "OXA-48-like",
        "vanA/B",
        "VIM",
        "Enterococcus faecalis",
        "Enterococcus faecium",
        "Listeria monocytogenes",
        "Staphylococcus spp.",
        "Staphylococcus aureus",
        "Staphylococcus epidermidis",
        "Staphylococcus lugdunensis",
        "Streptococcus spp.",
        "Streptococcus agalactiae (Group B)",
        "Streptococcus pneumoniae",
        "Streptococcus pyogenes (Group A)",
        "Acinetobacter calcoaceticus-baumannii complex",
        "Bacteroides fragilis",
        "Enteric bacteria",
        "Enterobacter cloacae complex",
        "Escherichia coli",
        "Klebsiella aerogenes",
        "Klebsiella oxytoca",
        "Klebsiella pneumoniae group",
        "Proteus spp.",
        "Salmonella spp.",
        "Serratia marcescens",
        "Haemophilus influenzae",
        "Neisseria meningitidis",
        "Pseudomonas aeruginosa",
        "Stenotrophomonas maltophilia",
        "Candida albicans",
        "Candida auris",
        "Candida glabrata",
        "Candida krusei",
        "Candida parapsilosis",
        "Candida tropicalis",
        "Cryptococcus neoformans/gattii"
    ],
    "Specimen Type(s)": [
        "Positive blood cultures"
    ],
    "Specimen Container(s)": [
        "Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioFire Blood Culture Identification 2 (BCID2) Panel",
        "FilmArray systems"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing",
        "Synthetic DNA control"
    ],
    "Methodologies": [
        "Qualitative nucleic acid detection",
        "Amplification",
        "Identification"
    ],
    "Submission Type(s)": [
        "Control Panel",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for FilmArray BCID2 Control Panel M416 assayed quality control material for nucleic acid-based clinical microbiology assays on BioFire BCID2 Panel",
    "Indications for Use Summary": "Intended for use as an external positive and negative assayed quality control to monitor performance of in vitro nucleic acid testing procedures for qualitative detection of antimicrobial resistance genes, bacteria, and yeast pathogens on BioFire BCID2 Panel assay using FilmArray systems; composed of synthetic DNA and used solely with the BCID2 Panel assay",
    "fda_folder": "Microbiology"
}